Rice Hall James & Associates LLC bought a new stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 62,129 shares of the company's stock, valued at approximately $989,000. Rice Hall James & Associates LLC owned approximately 0.14% of Avanos Medical as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently made changes to their positions in the business. Quarry LP bought a new position in Avanos Medical in the third quarter valued at $42,000. KBC Group NV increased its position in shares of Avanos Medical by 63.0% in the third quarter. KBC Group NV now owns 2,833 shares of the company's stock valued at $68,000 after acquiring an additional 1,095 shares during the last quarter. Intech Investment Management LLC bought a new stake in Avanos Medical during the third quarter worth about $207,000. Atom Investors LP acquired a new position in Avanos Medical during the third quarter valued at approximately $210,000. Finally, EP Wealth Advisors LLC bought a new position in Avanos Medical in the third quarter valued at approximately $212,000. 95.17% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Separately, StockNews.com cut Avanos Medical from a "strong-buy" rating to a "buy" rating in a research note on Sunday, November 3rd.
Get Our Latest Stock Report on AVNS
Avanos Medical Stock Performance
Shares of Avanos Medical stock traded up $0.01 during trading on Friday, hitting $15.49. 350,491 shares of the stock were exchanged, compared to its average volume of 432,212. Avanos Medical, Inc. has a 1-year low of $14.98 and a 1-year high of $25.36. The stock has a market capitalization of $711.78 million, a price-to-earnings ratio of 45.55 and a beta of 0.98. The company has a fifty day moving average price of $16.22 and a 200-day moving average price of $19.87. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.
About Avanos Medical
(
Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Stories
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
